Rekombinanter Human Respiratory Syncytial Virus Fusion Glycoprotein F0 (hRSV F0) Antikörper
Kurzübersicht für Rekombinanter Human Respiratory Syncytial Virus Fusion Glycoprotein F0 (hRSV F0) Antikörper (ABIN7574027)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Virus Strain
- strain A2
-
Expressionssystem
- Mammalian cells
-
Verwendungszweck
- Recombinant Anti-RSV F/Fusion glycoprotein F0 Antibody (4D7)
-
Aufreinigung
- Protein A or G purified from cell culture supernatant.
-
Reinheit
- >95 % by SDS-PAGE.
-
Isotyp
- IgG2a, kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Handhabung
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4°C short term (1-2 weeks). Store at -20 °C 12 months. Store at -80°C long term.
-
Haltbarkeit
- 12 months
-
-
-
: "Induction of neutralizing antibody responses by AAV5-based vaccine for respiratory syncytial virus in mice." in: Frontiers in immunology, Vol. 15, pp. 1451433, (2024) (PubMed).
-
-
- Human Respiratory Syncytial Virus Fusion Glycoprotein F0 (hRSV F0)
-
Andere Bezeichnung
- Human respiratory syncytial virus A Fusion glycoprotein F0
-
Substanzklasse
- Viral Protein
-
Hintergrund
- Fusion glycoprotein F0, Fusion glycoprotein F2, F2, p27, Intervening segment, Pep27, Peptide 27, Fusion glycoprotein F1, F1, F, post-fusion
Target
-